Arkolith/Insider Trading/ACOR/Form 4

Cohen Ron

President and CEO, DirectorAcorda Therapeutics, Inc. (ACOR) · full profile →Form 4 · filed Mar 20, 2023
Net Buying
Open-Market Buys
$13K
Open-Market Sells
$0
Net Open-Market Flow
$13K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 17, 2023Buy(P)10K$0.65$7K150K
Mar 16, 2023Buy(P)10K$0.60$6K140K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-020044) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML